Previous 10 | Next 10 |
Daré Bioscience (DARE +5.8%), which saw it shares soar ~30% on Tuesday following FDA approval of Xaciato (clindamycin gel) for bacterial vaginosis, has seen a chunk of those gains evaporate since then. While shares are up again today, since Monday's close through this...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Penny stocks are still a hot topic among retail traders and we’re covering some of the top ones to watch Wednesday that are on the move. Source: John Brueske/Shutterstock.com But before that, I do have to war...
Gainers: Inotiv (NASDAQ:NOTV) +13%, Theravance Biopharma (NASDAQ:TBPH) +11%, Biofrontera (NASDAQ:BFRA) +11%, Dare Bioscience (NASDAQ:DARE) +10%, Stereotaxis (NYSE:STXS) +8%. Losers: Radius Health (NASDAQ:RDUS) -43%, Ensysce Biosciences (NASDAQ...
Energy Focus (NASDAQ:EFOI) +52% launches nUVo virus-targeted UVC air disinfectors to public. Lexaria Bioscience (NASDAQ:LEXX) +25% dehydraTECHTM-CBD reduces arterial stiffness, results confirmed in human clinical study HYPER-H21-2. Dare Bioscience (NASDAQ:DARE) +23% announces F...
Prescribing information supports positioning of XACIATO as a first line option for the treatment of bacterial vaginosis This marks the first FDA-approved product in Daré’s portfolio of potential first in category development candidates Strat...
Daré Bioscience (DARE +10.5%) is trading sharply higher on the FDA approval of XACIATOTM (clindamycin phosphate) for the treatment of bacterial vaginosis in females aged 12 and above. In Q3 2021, the FDA had accepted the company’s marketing application for XACIATOTM with priority ...
Welcome to Seeking Alpha's Catalyst Watch - a breakdown of some of next week's actionable events that stand out. Check out Saturday morning's regular Stocks to Watch article for a full list of events planned for the week or the Seeking Alpha earnings calendar for companies due to report. Mond...
Are These Reddit Penny Stocks on Your List Right Now? If you’re looking for the best penny stocks to buy on Reddit, there’s no better time than right now. As a result of the major movement that is occurring in the stock market, there are plenty of opportunities to make m...
The following slide deck was published by Daré Bioscience, Inc. in conjunction with their 2021 Q3 earnings call. For further details see: Daré Bioscience, Inc. 2021 Q3 - Results - Earnings Call Presentation
Daré Bioscience, Inc. (DARE) Q3 2021 Earnings Conference Call November 10, 2021, 04:30 PM ET Company Participants Sabrina Martucci Johnson - President and CEO John Fair - Chief Strategy Officer Lisa Walters-Hoffert - CFO Conference Call Participants Zegbeh Jallah - ROTH Capital Partners ...
News, Short Squeeze, Breakout and More Instantly...
2024-07-01 09:02:05 ET Dare Bioscience Inc (DARE) announced stock split at a ratio of 1-for-12 on 2024-07-01 ... Full story available on KlickAnalytics.com
Shares Expected to Begin Trading on Split-Adjusted Basis on July 1, 2024 SAN DIEGO, June 27, 2024 (GLOBE NEWSWIRE) -- Daré Bioscience, Inc. (NASDAQ: DARE), a leader in innovation for the health and wellbeing of women, today announced that it will implement a 1-for-12 reverse split...
Phase 2b study demonstrated topical Sildenafil Cream, 3.6% improved outcomes among women with female sexual arousal disorder (FSAD), particularly in an exploratory subset of women with FSAD with or without concomitant decreased desire There are currently no FDA-approved therapies fo...